CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk

Clinical Trial2017 Apr 18;69(15):1913-1920.

JOURNAL:J Am Coll Cardiol. Article Link

Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction

Pöss J, Köster J, Fuernau G et al. Keywords: TIMI flow grade; acute coronary syndrome; mortality; percutaneous coronary intervention; prognosis; risk score; IABP-SHOCK II trial

FULL TEXT PDF